N6-methyladenosine-mediated up-regulation of ARRB2 regulates intrahepatic cholangiocarcinoma malignant progression and pemigatinib resistance through MAPK and Hippo signaling pathways. The gene discussed is ARRB2; the disease is intrahepatic cholangiocarcinoma.